arimoclomol has been researched along with riluzole in 2 studies
| Studies (arimoclomol) | Trials (arimoclomol) | Recent Studies (post-2010) (arimoclomol) | Studies (riluzole) | Trials (riluzole) | Recent Studies (post-2010) (riluzole) |
|---|---|---|---|---|---|
| 34 | 4 | 22 | 1,244 | 153 | 572 |
| Protein | Taxonomy | arimoclomol (IC50) | riluzole (IC50) |
|---|---|---|---|
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | 4.73 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 10 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.733 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.733 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liščić, RM | 1 |
| Andres, CR; Blasco, H; Corcia, P; Gordon, PH; Patin, F | 1 |
2 review(s) available for arimoclomol and riluzole
| Article | Year |
|---|---|
Molecular basis of ALS and FTD: implications for translational studies.
Topics: Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; Frontotemporal Dementia; Humans; Hydroxylamines; Mutation; Riluzole | 2015 |
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.
Topics: Amyotrophic Lateral Sclerosis; Biomarkers; Clinical Trials as Topic; Frontotemporal Dementia; Humans; Hydroxylamines; Memantine; Neuroprotective Agents; Riluzole; Superoxide Dismutase; Vitamin B 12 | 2016 |